Eloxx Pharmaceuticals Inc Analyst Call on Cystic Fibrosis Programs Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Eloxx Pharmaceuticals conference call and webcast on cystic fibrosis programs. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, John Woolford. John, you may begin.
Thank you. Good morning, and thank you to everyone who has joined today's call to discuss Eloxx Pharmaceuticals' cystic fibrosis program. An audio archive of this conference call will be available on the Eloxx Pharmaceuticals' website in the Investor Relations section later today. Also, please note that there are slides to accompany today's event. These slides are available through the webcast. Joining me today are Sumit Aggarwal, President and CEO; Dr. Vijay Modur, Head of Research and Development. In addition, we are pleased to have Dr. Eitan Kerem, a globally renowned CF expert with us on the call today.
Before we begin with prepared remarks,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |